AxoGen (AXGN) Tops Q3 EPS by 6c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $47.07 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• TechCreate Group faces NYSE American delisting proceedings